about
Exploring the potential of laser capture microdissection technology in integrated oral biosciences.HOPX functions as a tumour suppressor in head and neck cancer.DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity.Oral malignancy and premalignancy.Targeting HOX/PBX dimers in cancer.Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG OHPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6.Altered Toll-like receptor expression and function in HPV-associated oropharyngeal carcinoma.Using virtual microscopy to deliver an integrated oral pathology course for undergraduate dental students.Accuracy of staging of oral squamous cell carcinoma of the tongue: should incisional biopsy be done before or after magnetic resonance imaging?Errors in interpretation of neck levels in postoperative pathological specimens.Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.Extracellular vesicle microRNA cargo is correlated with HPV status in oropharyngeal carcinomaLumps and Bumps of the Gingiva: A Pathological MiscellanyKinase Regulation of HOX Transcription Factors.Unicystic ameloblastoma: Analysis of 370 cases in a single center in Sri LankaHuman papillomavirus (HPV) can establish productive infection in dysplastic oral mucosa, but HPV status is poorly predicted by histological features and p16 expressionSurgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' studyOdontogenic tumors and lesions treated in a single specialist oral and maxillofacial pathology unit in the United Kingdom in 1992-2016
P50
Q36118622-F2D68997-E57A-4DCD-9BD2-FA8E29373E9CQ37488079-5B4CD434-52AB-4013-B557-18644BCB207DQ38376361-BBCE2E09-AB8D-480D-A31C-B4224AAF72D1Q38806411-D8F37C3D-968E-4D53-8213-19FA3A87E3ADQ39250830-5D1DF5E2-77CB-49AB-BCC8-6724001BAF32Q42490655-EFC6F7E8-89DA-4EF1-AAC1-16E546DEBFDEQ46105096-52B54BC3-7184-48C1-8549-773FE8A7BCE4Q47593658-C456C870-49AD-4797-9FAD-27ADDDAAEEB0Q50128424-9F440DFA-F352-4F75-A1F0-00111AEAFA96Q50432144-311E28FA-6A75-49FA-8A01-49F0A833A7A9Q51790688-BCD37CA4-539B-48D5-8F0A-CB0B104A70BAQ52967500-E9DF9924-4AED-4778-9C40-D81B96840980Q55471239-0C6FC8B2-3BAF-4406-B2BD-863647BD2D45Q59352086-FDC97DE9-59F2-4FCB-9A1D-84C1AA856160Q64241200-E659C69C-496B-494D-B3EE-DE4D1662F220Q64982270-78C0CAEA-DAB6-43A5-8180-89575865DBB4Q88955555-3FABBD03-9255-4DD4-B570-E5E8A7E9883AQ90740978-187C632A-372B-4B77-BA22-A04046588321Q91451480-FFFD29EE-0849-42E7-BE84-0A7916DF26DEQ93192984-4D44CBB1-AE01-426D-8AF4-6D8923170334
P50
description
researcher ORCID ID = 0000-0002-7873-0877
@en
wetenschapper
@nl
name
Keith Hunter
@ast
Keith Hunter
@en
Keith Hunter
@es
Keith Hunter
@nl
type
label
Keith Hunter
@ast
Keith Hunter
@en
Keith Hunter
@es
Keith Hunter
@nl
prefLabel
Keith Hunter
@ast
Keith Hunter
@en
Keith Hunter
@es
Keith Hunter
@nl
P1153
8909576000
P31
P496
0000-0002-7873-0877